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ABSTRACT: We describe design and synthesis model of
multidomain (modular) peptides (MDPs), which direct a
reaction cascade coupling the synthesis and surface function-
alization of gold nanoparticles (AuNPs) in a single step. The
synthesis is achieved via simple mixing of the aqueous
solutions of auric acid and MDPs at room temperature
without the addition of any surfactants or toxic intermediate
reagents. This method allows facile control over the nano-
particle size between ∼2−15 nm, which opens a practical
window for biomedical applications. In contrast to the conventional citrate-mediated methods, peptide-mediated synthesis and
stabilization provide increased colloidal stability to AuNPs. As a proof of this concept, we demonstrate active targeting of human
breast adenocarcinoma cell line (MCF7) using the one-step-prepared engineered AuNPs. Overall, we propose a single-step,
chemically greener, biologically safer method for the synthesis and surface functionalization of gold nanoparticles in a size-
controlled manner. The chemical versatility of the MDP design broadens the applicability of this strategy, thereby emerging as a
successful alternative for the currently available nanoparticle preparation technologies.
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1. INTRODUCTION
Engineered gold nanoparticles (AuNPs) have drawn substantial
attention due to their unique optoelectronic and physicochem-
ical properties. Their exceptionally low cytotoxicity and high
chemical stability in biological media have also enabled an
extensive range of biomedical applications, such as drug or gene
delivery, photothermal therapy, colorimetric sensing, and
imaging.1−7 As targeting and delivery agents, application of
engineered AuNPs have reached early phase clinical trials.8 As a
result, preparation of AuNPs requires careful attention to
controlling engineering parameters, such as size, shape, and
surface coating, and purification of the final construct from
toxic reactants.
Functionalized AuNPs are usually prepared by two successive
reactions: In the first step, Au(III) ions are reduced into Au(0)
by either citrate ions or sodium borohydride to synthesize
nanoparticles in the range of 10−20 nm or 2−5 nm,
respectively.9−11 Alkanethiols, tetraoctylammonium bromide,
cetyltrimethylammonium bromide, or Tween-20 are used as
stabilizers for gold nanoparticles. In the second step, functional
(bio) organic molecules containing a disulfide group are used to
displace the intermediate stabilizer via a ligand exchange
reaction.12 However, this method of preparing functionalized
AuNPs has major drawbacks. For example, some portion of
reacting AuNPs irreversibly fuse at the instantaneously
destabilized sites to form larger aggregates during ligand
exchange reaction.13 In addition, this reaction does not go to
completion, which can significantly reduce functional ligand
density on the nanoparticle surface, thereby reducing the
expected effectiveness of the final construct. Moreover, toxic
surfactants such as tetraoctylammonium bromide or cetyltri-
methylammonium bromide are difficult to completely remove,
and their desorption from the AuNP surface induces cell
death.14
Efforts to overcome such drawbacks have focused on
developing novel chemical routes to prepare engineered
AuNPs in facile and robust manners in a single step. One
well-known approach of AuNP synthesis is reducing Au(III)
ions to Au(0) using sodium borohydride in the presence of
thiol-containing functional molecules, which cap the nano-
particle surface.15−17 Other studies used reductive hydrox-
yphenol derivatives for synthesis of AuNPs; however, they lack
the ability to modulate their functional groups according to the
desired application.18,19 Despite the progress, a practical
method that couples the synthesis and biofunctionalization
steps in one molecule in a chemically greener and biologically
safer way is needed to significantly improve the usefulness of
the nanoparticles, particularly in biomedical applications.
Received: September 17, 2014
Accepted: May 5, 2015
Published: May 5, 2015
Research Article
www.acsami.org
© 2015 American Chemical Society 10677 DOI: 10.1021/acsami.5b00093
ACS Appl. Mater. Interfaces 2015, 7, 10677−10683
In the present study, we describe design of multidomain
peptides (MDPs) for single-step, size-controlled synthesis of
biofunctionalized AuNPs (Figure 1). Synthesis of AuNPs with
MDPs relies on 3,4-dihydroxy-L-phenylalanine (Dopa) resi-
dues, a mussel-inspired residue known for its reductive role to
facilitate rapid curing of the mussel glue under water.20 We
showed that Dopa couples its oxidation to the reduction of Au
(III) ions, thereby leading to the formation of AuNPs.
Furthermore, Dopa-mediated MDP design enables concerted
reduction, stabilization and functionalization all by the same
molecule at one-pot, whereby no additional reagent or reaction
is needed. MDPs also provide geometrically flexible space for
the presentation of the biofunctional ligand to the outer
environment. In contrast to the existing methods, inherent
biocompatibility of the peptide provides a greener route toward
the synthesis of broad-range (∼2−15 nm in diameter)
biofunctional nanoparticles. Moreover, this strategy is free of
inefficiencies that might arise during the ligand exchange
reaction. As a result, these AuNPs exhibit remarkable stability in
high ionic strength. As proof of this concept, we synthesized
AuNPs functionalized with a targeting moiety, Arg-Gly-Asp
peptide, which is known to bind to integrin αvβ3, upregulated
on cancer cell surface.21 Synthesized MDP-capped AuNPs were
exposed to MCF7 cells, and uptake was confirmed by
transmission electron microscopy (TEM) and inductively
coupled plasma mass spectrometry (ICP-MS) analyses. Overall,
the strategy here provides a practical and toxicity-free
alternative to the currently established methods for preparation
of functionalized AuNPs.
2. EXPERIMENTAL SECTION
2.1. Materials. All chemicals and materials used in this study were
analytical grade and purchased from Invitrogen, Thermo-Fisher,
Merck, Alfa Aesar, ABSR, Millipore, and Sigma-Aldrich.
2.2. Synthesis and Characterization of MDPs. Peptide
synthesis was achieved using solid-phase peptide synthesis with 9-
fluorenylmethoxycarbonyl (Fmoc) chemistry. Rink amide MBHA
resin was used as the solid platform. At each coupling step, Fmoc at Nα
was removed with 20% piperidine/dimethylformamide (DMF)
solution in 20 min. For activation of carboxylate groups, 2 equiv of
amino acids were mixed with 1.95 equiv of N,N,N′,N′-Tetramethyl-O-
(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) and 3
equiv of N,N-Diisopropylethylamine (DIAE) for 1 equiv of resin. After
each coupling step, 10% acetic anhydride/DMF solution was used to
permanently acetylate the unreacted amine groups. A cleavage cocktail
containing 95% trifluoroacetic acid (TFA), 2.5% water, and 2.5%
triisopropylsilane (TIS) was used to remove all the protecting groups
at the end of coupling steps. Excess TFA removal was achieved by
rotary evaporation followed by precipitation in diethyl ether at −20 °C
overnight. The precipitate was then dissolved in ultrapure water,
frozen at −80 °C, and lyophilized for 1 week. Residual TFA was
removed with dilute HCl treatment two times. Other small impurities
were removed by dialysis using cellulose ester membrane with a
molecular weight cutoff of 100−500 Da. Synthesized peptides were
characterized using Agilent 6530 quadrupole time-of-flight (Q-TOF)
mass spectrometry with electrospray ionization (ESI) source equipped
with a reverse-phase analytical HPLC (Figure S1, SI). Peptide batches
were always stored as lyophilized powders at −20 °C. For each
experiment, freshly dissolved aqueous peptide solutions were prepared.
The pH of the solution was adjusted using 1 M HCl(aq) and 2 M
NaOH(aq).
2.3. Characterization of AuNPs. For the characterization of the
AuNPs, the solution was purified by centrifugal filtering using
Figure 1. Schematic illustration of the MDP design for one-step synthesis and surface modification of AuNPs. (a) Chemical sketch of a proof-of-
concept MDP, RGDSGGGGKDopa-Am, where Dopa and Lys serve as synthesis and stabilization units, Gly4 functions as a steric linker to Arg-Gly-
Asp-Ser, an integrin-binding peptide sequence. (b) Proposed synthesis and surface modification (capping) of AuNPs with the peptides.
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Millipore Amicon Ultra-4 centrifugal filter units at 5000 rpm for 5 min
with 10 repeats, in each of which ∼2/3 of continuous water phase was
removed and then replaced with fresh ultrapure water. Final pure
AuNP solution was stored at room temperature for months without
observing any macroscopic destabilization. Unless otherwise men-
tioned, all characterizations of AuNPs were carried out in ultrapure
water. Spectral and kinetic analyses of AuNPs were performed with
SpectraMax M5Multi-Mode Microplate Reader. A spectral range of
250−750 nm was scanned with 2 nm increments. Kinetics of the
synthesis was monitored by recording spectral absorbance at 518 nm
(around the center of surface plasmon resonance (SPR)) in 3 min
intervals for a period of 1 h. A magnetic stirrer in the
spectrophotometer enabled homogeneous sample distribution
throughout the readings. Recording was started immediately after
pH adjustment to ∼10. Transmission electron microscopy (TEM)
images of AuNPs were obtained with FEI Tecnai G2 F30 series at 300
kV. The samples were prepared by dropping AuNP solution on a
carbon-coated copper grid followed by air-drying. Core size
distribution of AuNPs was determined based on the TEM images.
Hydrodynamic size distribution and zeta potential of AuNPs were
measured using a Malvern Zeta Sizer NanoZS. Dynamic light
scattering (DLS) was carried out with AuNPs dispersed in ultrapure
water following the purification step described above. Prior to the DLS
measurement, the samples were vortexed and treated with ultrasound
sonication and then equilibrated at rest for 5 min. For the automated
zeta size measurements, AuNPs dispersed in ultrapure water were
titrated with 0.01 M HCl and 0.01 M NaOH. A magnetic stirrer
enabled continuous stirring for equilibration. All results are the
averages of at least three independent measurements.
2.4. Colloidal Stability of AuNPs. Colloidal stability of AuNPs
was investigated by monitoring the impact of ionic strength on the
SPR of AuNPs. Citrate-capped AuNPs was used as the negative
control. Both citrate- and peptide-capped AuNPs in the same molar
concentrations and the same average core sizes (11 nm) were
incubated in a series of increasing sodium chloride (NaCl)
concentrations (0−250 mM). The mixtures were allowed for
stabilization for 1 h. Then, the SPR centers were determined by
scanning in the range of 250−750 nm with 2 nm increments.
2.5. Ligand Density on Gold Nanoparticles. Bound-peptides
on AuNPs were determined using Pierce BCA Protein Assay Kit.
Samples were prepared according to the recommendation of the
manufacturer. Briefly, AuNPs were purified with centrifugal filtration
as explained above in order to remove any unbound peptide residue
from the solution. Then, peptides bound on AuNPs were reacted with
Cu2+ to produce spectrophotometrically quantifiable blue-violet color,
which is indicative of Cu1+ (biuret reaction). To intensify this signal,
we coordinated Cu1+ ions with bicinchoninic acid and recorded the
resulting absorbance at 562 nm.22 Standard curves for peptides were
prepared using unreacted peptide solutions.
2.6. In Vitro Characterization of AuNP Uptake. MCF7 cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin in standard cell culture conditions (37 °C, 5% CO2, and
95% humidity). Prior to the uptake assay, cytotoxicity of MDP-capped
AuNPs was investigated with a dose response colorimetric cellular
viability (MTT) assay. MCF7 cells were incubated with serially
increasing concentrations of 11 nm MDP-capped AuNPs (12.5, 25,
and 50 μg mL−1). After 3 h of incubation, MDP-capped AuNPs did
not elicit any significant loss in cell viability (Figure S2, SI). This result
designated the biocompatibility of the MDP-capped AuNPs within the
concentration range of 50 μg mL−1. To determine the uptake pathway
of the engineered AuNPs, we inhibited three major endocytosis
pathways. Then, the resulting amount of the AuNP uptake was
compared. For this, MCF7 cells were grown on 96-well plates until
they reached 80−90% confluency. Prior to adding engineered AuNPs,
cells were incubated with one of following inhibitors prepared in
serum-free DMEM for 1 h: amiloride (5 mM), chlorpromazine (5 μg
mL−1), or Filipin III (50 nM). After 1 h, the inhibitors were removed,
and 25 μg mL−1 AuNPs were introduced to cells in serum-free fresh
media supplemented with the inhibitors. For the uptake experiments,
serum-free DMEM containing 1% penicilin/streptomycin was used in
order to avoid nonspecific interactions. MCF7 cells were incubated
with the nanoparticles for 4 h. Uptake was then terminated by
Figure 2. Synthesis, kinetics and colloidal stability of AuNPs. (a) UV−vis spectrum of the peptide-gold solution mixture at 1 h. The inset shows the
reaction tube. Solution develops wine red color in 1 h, a typical indicative of AuNPs. (b) Particle size distribution and (c) transmission electron
micrographs of AuNPs. (d) Kinetics of nanoparticle formation monitored by the light absorption of surface plasmons at 518 nm. (e) Colloidal
stability of MDP-capped AuNPs as compared to citrate-capped AuNPs with the same average size. (MDP: 0.6 mM; H[AuCl4]: 19.2 mM; [MDP]:
[Au (III)] = 1:32).
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removing the medium and thoroughly washing the cells with
phosphate buffered saline (PBS, pH 7.4). The samples were digested
using aqua regia (HCl:HNO3 3:1) overnight. These lysates were then
transferred to 2% nitric acid. Gold ions in the lysates were quantified
through inductively coupled plasma-mass spectrometry (ICP-MS,
Thermo X Series II). A standard curve was prepared by dissolving and
serially diluting 1 ppm of H[AuCl4] in 2% nitric acid to obtain 12.5,
6.25, 3.125, 1.56, and 0.78 ppb standard gold concentrations.
2.7. Statistical Analysis. All experiments were analyzed in
triplicates or quadruplicates, with at least two independent repeats.
Error bars represent standard error of the mean (SEM). Statistical
significance was determined using one-way ANOVA with a confidence
interval of P < 0.05.
3. RESULTS AND DISCUSSION
A short multidomain peptide (MDP) was designed and
synthesized to concertedly carry out three separate tasks
required for the synthesis and functionalization of AuNPs
(Figure 1a): (1) Mussel-inspired Dopa has a catechol side
chain, which has suitable reduction potential (E0-Dopa = −745
mV) to reduce gold ion into gold atom (E0-Au(III) = +1.52 V)
at pH 7.18,23,24 In addition, the catechol could bind to various
metals, oxides and metal ions.20 In this regard, Dopa was
chosen to serve as both reducing and stabilizing agents. Lysine
residues assisted further stabilization of AuNPs. (2) Linker
domain aimed to form a steric interface between AuNP binding
domain and the following functionalization domain. This
domain can also be considered as a secondary functionalization
domain for multitasking complex applications. For example,
glycine can be replaced with positively charged residues, such as
histidine, to serve as carriers for nucleotides in gene delivery
applications or as endosome-escaping proton sponges.25,26 (3)
For active targeting in biological environment, we further
included an integrin-targeting domain, comprised of arginine-
glycine-aspartate. AuNPs were typically synthesized by the
route outlined in Figure 1b. MDP solution (1 mL, 0.6 mM, pH
∼3) was allowed to react with an equal volume of H[AuCl4]
solution (19.2 mM) ([MDP]:[Au(III)] = 1:32) at room
temperature. Immediately after the Au3+ and MDP solutions
were mixed, the container tube was thoroughly vortexed for 10
s. Then, pH of this solution was elevated to ∼10 by 2 M
NaOH(aq), vortexed immediately and vigorously for 10 s, and
incubated at room temperature for 1 h by continuous stirring.
pH elevation triggered spontaneous oxidation of catechol,
which was coupled to the reduction of Au3+.27 This redox
coupling was demonstrated by the spectral monitoring of the
reaction. Immediately after the Au3+ solution was mixed with
the MDP solution, a bathochromic shift was observed from 280
nm (attributable to catechol) to around 350 nm (attributable to
quinone).28 Upon pH elevation, this quinone peak started to
diminish along with a global increase in the visible range of the
spectrum. At the end of 1 h, characteristic SPR peak became
evident at 518 nm (Figure 2a). This was also detectable by eye
as the yellow-gold solution turned into wine-red in 1 h (Figure
2a, inset). To confirm the formation of nanoparticles, we
investigated samples using TEM, which showed spherical
nanoparticle formation with an average core size of 11.0 ± 1.9
nm (Figure 2b,c). Energy dispersive X-ray (EDX) spectrum
verified the presence of AuNPs (Figure S3, SI). Selected-area
electron diffraction (SAED) patterns finally revealed specific
lattices pertaining to polycrystalline AuNPs (Figure S3, inset,
SI). In water, the hydrodynamic size of these AuNPs was found
to be 14.5 ± 0.8 nm. Compared to the core nanoparticle size
(obtained from TEM micrographs), higher hydrodynamic size
obtained from DLS measurements is attributable to the
solvation effect and the presence of the peptide cap. DLS
measurements further confirmed that there was no aggregation
in the solution, at least over the time-scale of the measure-
ments. The unique wine-red color of the solution remained
unchanged for over a year, a further indication of the
nanoparticle stability. Zeta potentials of MDP-AuNPs in
water were measured over a pH range of 2.5−11.5 (Figure
S4, SI). Nanoparticles were slightly positive and neutral at
acidic and neutral pH values, whereas they were negatively
charged at basic pH. This amphoteric behavior was attributed
to the peptide capping, of which pH-dependent net charge
affects the surface charge of the nanoparticle.
Kinetics of AuNP formation was monitored by time-wise
tracking of the surface plasmon resonance at 518 nm.
Nanoparticle formation started within seconds after the
initiation of the reaction, that is, the pH elevation, and reached
equilibrium at room temperature within 1 h (Figure 2d).
Compared to the existing synthesis techniques, which usually
require boiling of the gold solution to prepare monomeric
precursors for nucleation, using MDPs enabled a much milder
route in a comparatively faster reaction scheme. Surface
functionalization of AuNPs with MDPs was demonstrated by
the colloidal stability of the nanoparticles against the ionic
strength (Figure 2e). MDP-capped AuNP dispersions were
relatively stable in up to 100 mM NaCl salt concentration. On
the other hand, citrate-capped AuNPs started to coagulate after
62 mM NaCl with further red shifting in SPR bands with
increasing NaCl concentrations. As a result, it was concluded
that MDP functionalization, ascribed to the strong binding
capacity of Dopa to metals, provided steric stability to
AuNPs.20 Mechanism of gold nanoparticle formation was
analyzed by UV−vis spectroscopy (Figure S5, SI). Before the
addition of gold salt into the MDP solution at pH 5, Dopa
adsorption peak at 280 nm was detected. When the pH of the
peptide solution was increased to 10, a broad shoulder ranging
from 300 to 500 nm indicating the oxidized quinone formation
was observed. Aqueous H[AuCl4] solution shows an intense
band around 320 nm due to charge transfer between the metal
and chloride ions.29 As soon as aqueous H[AuCl4] was mixed
with MDP solution at pH 10, this peak vanished corresponding
to the complete reduction of Au(III). This is because of the
high reduction potential of Dopa, which gave electrons to
Au(III) ions to instantly generate gold nanoparticles and
converted into quinones.18,24 Within 1 h, the color of the
solution almost completely turned wine-red along with the
maximum SPR peak value at 518 nm, indicating that AuNP
formation has reached into equilibrium.
The ability to synthesize AuNPs at varying sizes with a
narrow distribution is highly important, as the size dictates the
ultimate colloidal, physicochemical, and optoelectronic proper-
ties of the nanoparticles. Synthesis of size-controlled AuNPs
was carried out by mixing serially diluted H[AuCl4] solutions
(from 76.8 to 1.2 mM with a dilution factor of 2) with MDP
(0.6 mM, pH ∼3) at equal volumes. As described previously,
the reaction was initiated by pH elevation. We observed that
color of the solutions varied from bright orange (1:128
peptide/gold molar ratio) to wine-red (1:32) and to light-pink
(1:2), which represented the unique characteristics of nano-
particles in the order of increasing core size (Figure 3a).
Concomitant with the color change, SPR bands of synthesized
AuNPs shifted to longer wavelengths with decreasing amounts
of gold salt ratio in the initial solution (Figure 3b). Indeed, core
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size analysis by TEM revealed that particle size increases
progressively with decreasing amounts of gold salt in the initial
solution (Figure S6, SI). The average diameters extracted from
TEM images along with their Au-to-peptide ratios are listed in
Table 1. The size distributions were concordant with the results
previously reported by using catechol chemistry to synthesize
AuNPs.23 Using this chemistry, we were able to synthesize
MDP-capped AuNPs with controlled sizes ranging from 2.3 to
15.5 nm in diameter. Further, size distribution of MDP-capped
AuNPs were about ∼20% of their average core sizes, which is a
significant improvement compared to the particle size
distribution of AuNPs synthesized with previously reported
one-pot preparation methods.19,23 Because of their small size
(2.3 nm), particles with 1:128 molar ratio did not exhibit SPR
band.11,30 We conclude that the ability of the multidomain
peptide to separate and concert nucleation and growth phases
of nanoparticle formation enabled fine-tuned synthesis with a
narrow size distribution.
To show the versatility of the multidomain peptide approach,
we used additional peptides with altered or cleaved sequences
to synthesize engineered AuNPs in one pot (Figure S7a, SI).
AuNPs syntheses with the same one-pot technique were
accomplished within 1 h (Figure S7b, SI). In terms of colloidal
stability, all MDP-capped AuNPs showed higher stability than
citrate-capped AuNPs in increasing ionic strength conditions
(Figure S7c, SI). TEM micrographs demonstrated P2-AuNPs
from 2.3 to 26.1 nm with an average size distribution of 22.5%.
P3-AuNPs had a smaller size range from 9.8 to 13.3 nm with an
average size distribution of 17.8%. Due to the shorter peptide
sequence of P3, compared to P1 and P2, nanoparticles smaller
than 10 nm were prone to aggregation owing to the decreased
steric shielding in the presence of high ionic strength.
The uptake of MDP-capped AuNPs was analyzed by
incubating monolayers of MCF7 cells with synthesized gold
nanoparticles. MCF7 cells have previously been treated with
RGD-functionalized targeting agents, because αvβ3 integrins
exhibited on the cell surface recognizes this short peptide
sequence.31−33 Protein agglomeration on nanoparticle surfaces
introduces new epitopes for cellular uptake and therefore
enhances endocytosis.34 To prevent such nonspecific enhance-
ment of endocytosis, we performed uptake experiments in
serum-free media. TEM micrographs revealed that nano-
particles were internalized by MCF7 cells (Figure S8, SI).
During endocytosis, cell membranes with receptors “wrap”
around a particle coated with matching ligands.35 Eleven nm
MDP-AuNPs formed clusters in order to enter the cell. This is
compatible with the models developed to understand the
dynamics of endocytosis such that a single NP smaller than 50
nm does not produce enough free energy to completely wrap
the membrane around the NPs.35 Hence, the nanoparticles
were mainly clustered in order to be uptaken by the cells.
Understanding the mechanisms of internalization is critical to
design nanoparticles precisely for specific purposes. To obtain a
deep understanding of MDP-capped AuNP uptake, we
analyzed their internalization mechanisms and pathways in
MCF7 cells. Although internalization mechanisms are really
diverse, they generally are classified into three main groups:
clathrin mediated, lipid raft/caveolae mediated, and macro-
pinocytosis/phagocytosis.36 Chemical inhibition of these path-
ways are regularly used in biology.37 Amiloride, which blocks
macropinocytosis; chlorpromazine, which prevents the for-
mation of clathrin coated pits; and filipin III, which inhibits
caveole mediated uptake, were incubated with the cells for 1
h.38 Then solutions containing MDP-capped AuNPs (25 μg
mL−1) and each inhibitor were added to the culture media and
incubated for an additional 4 h. The resulting cells were lysed
and subjected to ICP-MS for the detection of gold content.
Cells that were not exposed to nanoparticles were used as
negative control and cells that were not exposed to inhibitors
were used as positive control. The quantitative gold analysis
revealed that MDP-capped AuNPs enter into MCF7 cells by
several pathways (Figure 4). Amiloride and chlorpromazine
significantly inhibited 68 and 39% of the nanoparticles uptaken
by cells, respectively. This indicated the role of macro-
pinocytosis and clathrin-mediated endocytosis (CME) in
MDP-capped AuNP uptake. Filipin III, on the other hand,
had no effect on uptake suggesting that caveole-mediated
uptake might not be involved in endocytosis of MDP-capped
AuNPs. Collectively, these results supported the strong
involvement of CME and macropinocytosis in the uptake of
MDP-capped AuNPs by MCF7 cells.
Figure 3. Size-controlled one-pot synthesis of MDP functionalized
AuNPs. (a) Size-dependent color development in the reaction tubes.
(b) Normalized UV−vis spectra of MDP-capped AuNPs showing a
consistent red-shift as the [Au (III)]:[MDP] ratio decreases.
Table 1. Size and Surface Characteristics of MDP-Capped
AuNPs: Core Size, Estimated Number of Gold Atoms per










128 2.3 ± 0.7 376 na
64 7.0 ± 1.3 10597 191
32 11.0 ± 1.9 41123 627
16 12.8 ± 2.1 64642 755
8 14.3 ± 3.1 90726 1741
4 15.5 ± 2.9 115053 2115
2 15.0 ± 2.2 105951 2150
aMolar ratios of MDP solution and gold solution used to synthesize
various sized MDP-capped AuNPs. bCore size was determined by
>300 particle counts in each group from TEM images. cThe average
number (N) of gold atoms per nanoparticle was calculated assuming
that AuNPs are spherical with a uniform fcc structure with the
following equation.39 N = 30.89602D.3 dLigand number per
nanoparticle was estimated by the colorimetric staining of peptides.
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4. CONCLUSION
Here, we describe a simple, robust, and greener way to prepare
engineered gold nanoparticles (AuNPs). The strategy intro-
duced here circumvents the major obstacles of the conventional
methods with potentially toxic byproducts, extended synthesis
times, engineering efficiency, and poor size control. Mussel-
inspired Dopa modification of MDPs could devise synthesis,
capping, and functionalization of AuNPs without requiring
additional stabilizer, strong reducing agent, or toxic surfactant
in a single step. Engineered AuNPs had long-term stability and
high ionic strength provided by the peptide capping. Controlled
synthesis of AuNPs with MDPs enabled the stable formation of
AuNPs in the range of 2−15 nm. It is still unclear why there is
an inverse relationship between particle core size and the
relative gold precursor amount in the solution. A similar result
has previously been reported using catechol chemistry to
synthesize AuNPs.23 This observation deserves a more careful
future investigation to better understand routes for nanoparticle
synthesis and stabilization. Nonetheless, the resulting nano-
particle size range is within biomedical values, indicating that
the AuNPs could potentially be used as drug and gene carriers,
in photothermal therapy, and in screening applications. MDP-
capped AuNPs showed excellent biocompatibility along with
targeted cellular uptake through CME and macropinocytosis.
One can optimize the design of AuNPs for various applications
by modularly modifying MDP sequences.
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